Prot #RIN‐PF‐302: An Open‐label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Project: Research project

Project Details

StatusActive
Effective start/end date8/18/238/18/26

Funding

  • United Therapeutics Corporation (Prot #RIN-PF-302)